Insider transactions

EDGAR

MapLight Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
10 transactions, 5,663,969 shares
Sum of shares × price per share: 66,229,342.1075
Open-market sales (code S)
145 transactions, 1,118,271 shares
Sum of shares × price per share: 30,239,360.15

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 203

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-15 Filed 2026-10-16GILLIS JONATHAN Officer: CAO and Interim CFO
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)10,1678.08
82,149.36

Derived: shares × price per share. Exact value 82149.36.

142,315Direct (D) No
F1, F2
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001709954-26-000014 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Kroeger Christopher A. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)73,6918.08
595,423.28

Derived: shares × price per share. Exact value 595423.28.

1,195,909Direct (D) No
F1, F2
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001658918-26-000018 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Foff Erin Pennock Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)15,3558.08
124,068.4

Derived: shares × price per share. Exact value 124068.40.

296,906Direct (D) No
F1, F2
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021233-26-000016 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Hanson Kristopher Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)9,0208.08
72,881.6

Derived: shares × price per share. Exact value 72881.60.

128,024Direct (D) No
F1, F2
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001789970-26-000018 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Kreitzer Anatol Officer: Chief Discovery Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)12,2487.84
96,024.32

Derived: shares × price per share. Exact value 96024.32.

168,678Direct (D) No
F1
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
Open filing 0002021238-26-000014 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-16Lillie James Woodruff Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)11,5138.08
93,025.04

Derived: shares × price per share. Exact value 93025.04.

198,597Direct (D) No
F1, F2
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.755 to $8.3732 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001728746-26-000018 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-18Hanson Kristopher Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)16,50911.67
192,660.03

Derived: shares × price per share. Exact value 192660.03.

137,044Direct (D) Yes
F1, F2
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.38 to $12.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001789970-26-000016 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Kroeger Christopher A. Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Voting Common Stock
Acquired (A)23,1450—1,269,600Direct (D) No
F1, F2
  • F1 Represents a restricted stock unit (RSU) award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
  • F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Open filing 0001658918-26-000016 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Kroeger Christopher A. Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Voting Common Stock (93,955) — exercise price 11.245
Acquired (A)93,9550—93,955Direct (D) No
F4
  • F4 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001658918-26-000016 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19GILLIS JONATHAN Officer: CAO and Interim CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Voting Common Stock
Acquired (A)6,0200—150,260Direct (D) No
F1, F2
  • F1 Represents a restricted stock unit (RSU) award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
  • F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Open filing 0001709954-26-000012 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19GILLIS JONATHAN Officer: CAO and Interim CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Voting Common Stock
Acquired (A)2,2220—152,482Direct (D) No
F3, F2
  • F3 Represents an RSU award. The RSUs shall vest in 8 equal quarterly installments commencing on October 1, 2026, subject to the Reporting Person's continued service through each vesting date.
  • F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Open filing 0001709954-26-000012 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19GILLIS JONATHAN Officer: CAO and Interim CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Voting Common Stock (24,455) — exercise price 11.245
Acquired (A)24,4550—24,455Direct (D) No
F4
  • F4 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001709954-26-000012 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19GILLIS JONATHAN Officer: CAO and Interim CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Voting Common Stock (2,813) — exercise price 11.245
Acquired (A)2,8130—2,813Direct (D) No
F5
  • F5 The option share vest in 24 equal monthly installments commencing on August 1, 2026, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001709954-26-000012 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Kreitzer Anatol Officer: Chief Discovery Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Voting Common Stock
Acquired (A)6,0200—180,926Direct (D) No
F1, F2
  • F1 Represents a restricted stock unit (RSU) award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
  • F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Open filing 0002021238-26-000012 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Kreitzer Anatol Officer: Chief Discovery Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Voting Common Stock (24,455) — exercise price 11.245
Acquired (A)24,4550—24,455Direct (D) No
F3
  • F3 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Open filing 0002021238-26-000012 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Lillie James Woodruff Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Voting Common Stock
Acquired (A)7,7300—210,110Direct (D) No
F1, F2
  • F1 Represents a restricted stock unit (RSU) award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
  • F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Open filing 0001728746-26-000016 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Lillie James Woodruff Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Voting Common Stock (31,395) — exercise price 11.245
Acquired (A)31,3950—31,395Direct (D) No
F3
  • F3 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001728746-26-000016 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Foff Erin Pennock Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Voting Common Stock
Acquired (A)13,3600—312,261Direct (D) No
F1, F2
  • F1 Represents a restricted stock unit (RSU) award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
  • F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Open filing 0002021233-26-000014 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Foff Erin Pennock Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Voting Common Stock (54,240) — exercise price 11.245
Acquired (A)54,2400—54,240Direct (D) No
F3
  • F3 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Open filing 0002021233-26-000014 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Hanson Kristopher Officer: General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Voting Common Stock
Acquired (A)7,7300—153,553Direct (D) No
F1, F2
  • F1 Represents a restricted stock unit (RSU) award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
  • F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
Open filing 0001789970-26-000014 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-19Hanson Kristopher Officer: General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (right to buy) — underlying Voting Common Stock (31,395) — exercise price 11.245
Acquired (A)31,3950—31,395Direct (D) No
F3
  • F3 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Open filing 0001789970-26-000014 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-18Catalyst4, Inc. 10% owner
P

Open market or private purchase of non-derivative or derivative security

Voting Common Stock
Acquired (A)4,400,00011.38
50,072,000

Derived: shares × price per share. Exact value 50072000.00.

25,306,689Indirect (I) See footnoteNo
F1
  • F1 The shares are held of record by Catalyst4, Inc. (Catalyst4). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.
Open filing 0001900201-26-000005 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-18Catalyst4, Inc. 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants (right to buy) — underlying Voting Common Stock (2,928,686) — exercise price 0.0001
Acquired (A)2,928,68611.3799
33,328,153.8114

Derived: shares × price per share. Exact value 33328153.8114.

2,928,686Indirect (I) See footnoteNo
F2, F3, F1
  • F2 The warrant is immediately exercisable, however, the warrant may not be exercised if the aggregate number of shares of voting common stock beneficially owned by the reporting person immediately following such exercise would exceed 49.99%.
  • F3 The warrants will not expire until exercised in full.
  • F1 The shares are held of record by Catalyst4, Inc. (Catalyst4). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.
Open filing 0001900201-26-000005 Read from the filing’s XML Dispute this row
2026-08-03 Filed 2026-08-04Lillie James Woodruff Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)22,08212.54
276,908.28

Derived: shares × price per share. Exact value 276908.28.

202,380Direct (D) Yes
F1, F2
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.12 to $12.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001728746-26-000014 Read from the filing’s XML Dispute this row
2026-07-30 Filed 2026-07-30Catalyst4, Inc. 10% owner
P

Open market or private purchase of non-derivative or derivative security

Voting Common Stock
Acquired (A)1,000,00013
13,000,000

Derived: shares × price per share. Exact value 13000000.

20,906,689Indirect (I) See footnoteNo
F2
  • F2 The shares are held of record by Catalyst4, Inc. (Catalyst4). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.
Open filing 0001900201-26-000003 Read from the filing’s XML Dispute this row
2026-07-29 Filed 2026-07-30Catalyst4, Inc. 10% owner
P

Open market or private purchase of non-derivative or derivative security

Voting Common Stock
Acquired (A)3,00012.63
37,890

Derived: shares × price per share. Exact value 37890.00.

19,906,689Indirect (I) See footnoteNo
F2
  • F2 The shares are held of record by Catalyst4, Inc. (Catalyst4). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.
Open filing 0001900201-26-000003 Read from the filing’s XML Dispute this row
2026-07-28 Filed 2026-07-30Catalyst4, Inc. 10% owner
P

Open market or private purchase of non-derivative or derivative security

Voting Common Stock
Acquired (A)141,08810.7416
1,515,510.8608

Derived: shares × price per share. Exact value 1515510.8608.

19,838,552Indirect (I) See footnoteNo
F1, F2
  • F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.295 to $11.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
  • F2 The shares are held of record by Catalyst4, Inc. (Catalyst4). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.
Open filing 0001900201-26-000003 Read from the filing’s XML Dispute this row
2026-07-28 Filed 2026-07-30Catalyst4, Inc. 10% owner
P

Open market or private purchase of non-derivative or derivative security

Voting Common Stock
Acquired (A)65,13711.6891
761,392.9067

Derived: shares × price per share. Exact value 761392.9067.

19,903,689Indirect (I) See footnoteNo
F3, F2
  • F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.31 to $12.00, inclusive.
  • F2 The shares are held of record by Catalyst4, Inc. (Catalyst4). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.
Open filing 0001900201-26-000003 Read from the filing’s XML Dispute this row
2026-07-28 Filed 2026-07-28Cox Troy Director
P

Open market or private purchase of non-derivative or derivative security

Voting Common Stock
Acquired (A)15,6209.52
148,702.4

Derived: shares × price per share. Exact value 148702.40.

15,620Indirect (I) By trustNo
F1, F2
  • F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.305 to $9.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • F2 The shares are held by the Troy M Cox Adeo C Alday JT Revocable Trust dtd 5/28/25, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.
Open filing 0001696923-26-000007 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-20GILLIS JONATHAN Officer: CAO and Interim CFO
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)60036.51
21,906

Derived: shares × price per share. Exact value 21906.00.

162,109Direct (D) Yes
F6, F7
  • F6 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001709954-26-000010 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-20GILLIS JONATHAN Officer: CAO and Interim CFO
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)16,96937.61
638,204.09

Derived: shares × price per share. Exact value 638204.09.

145,140Direct (D) Yes
F6, F8
  • F6 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025.
  • F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001709954-26-000010 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-20GILLIS JONATHAN Officer: CAO and Interim CFO
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)90038.17
34,353

Derived: shares × price per share. Exact value 34353.00.

144,240Direct (D) Yes
F6, F9
  • F6 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025.
  • F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001709954-26-000010 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-20Kreitzer Anatol Officer: Chief Discovery Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)2,83337.05
104,962.65

Derived: shares × price per share. Exact value 104962.65.

189,246Direct (D) Yes
F6, F7
  • F6 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.36 to $37.335 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021238-26-000010 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-20Kreitzer Anatol Officer: Chief Discovery Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)14,14037.70
533,078

Derived: shares × price per share. Exact value 533078.00.

175,106Direct (D) Yes
F6, F8
  • F6 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025.
  • F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.36 to $38.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021238-26-000010 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-20Kreitzer Anatol Officer: Chief Discovery Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)20038.39
7,678

Derived: shares × price per share. Exact value 7678.00.

174,906Direct (D) Yes
F6
  • F6 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 24, 2025.
Open filing 0002021238-26-000010 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17Lillie James Woodruff Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)2,07737.90
78,718.3

Derived: shares × price per share. Exact value 78718.30.

224,462Direct (D) No
F1, F6
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001728746-26-000012 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17Foff Erin Pennock Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)3,65637.90
138,562.4

Derived: shares × price per share. Exact value 138562.40.

298,901Direct (D) Yes
F4, F9
  • F4 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021233-26-000012 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17Hanson Kristopher Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)1,13037.90
42,827

Derived: shares × price per share. Exact value 42827.00.

145,823Direct (D) No
F1, F6
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001789970-26-000012 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17Kroeger Christopher A. Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)16,77937.90
635,924.1

Derived: shares × price per share. Exact value 635924.10.

1,246,455Direct (D) No
F1, F6
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001658918-26-000014 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-20GILLIS JONATHAN Officer: CAO and Interim CFO
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)6,97936.66
255,850.14

Derived: shares × price per share. Exact value 255850.14.

164,185Direct (D) Yes
F1, F4
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.12 to $37.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001709954-26-000010 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-20GILLIS JONATHAN Officer: CAO and Interim CFO
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)1,47637.44
55,261.44

Derived: shares × price per share. Exact value 55261.44.

162,709Direct (D) Yes
F1, F5
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $37.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001709954-26-000010 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-20Kreitzer Anatol Officer: Chief Discovery Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)7,46436.66
273,630.24

Derived: shares × price per share. Exact value 273630.24.

193,671Direct (D) Yes
F1, F4
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.12 to $37.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021238-26-000010 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-20Kreitzer Anatol Officer: Chief Discovery Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)1,59237.44
59,604.48

Derived: shares × price per share. Exact value 59604.48.

192,079Direct (D) Yes
F1, F5
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $37.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021238-26-000010 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Lillie James Woodruff Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)5,00936.45
182,578.05

Derived: shares × price per share. Exact value 182578.05.

230,077Direct (D) No
F1, F4
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001728746-26-000012 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Lillie James Woodruff Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)3,52637.26
131,378.76

Derived: shares × price per share. Exact value 131378.76.

226,551Direct (D) No
F1, F5
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001728746-26-000012 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Lillie James Woodruff Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)1237.96
455.52

Derived: shares × price per share. Exact value 455.52.

226,539Direct (D) No
F1
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
Open filing 0001728746-26-000012 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Foff Erin Pennock Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)9,16336.46
334,082.98

Derived: shares × price per share. Exact value 334082.98.

308,441Direct (D) Yes
F4, F7
  • F4 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021233-26-000012 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Foff Erin Pennock Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)5,86537.26
218,529.9

Derived: shares × price per share. Exact value 218529.90.

302,576Direct (D) Yes
F4, F8
  • F4 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002021233-26-000012 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Foff Erin Pennock Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)1937.96
721.24

Derived: shares × price per share. Exact value 721.24.

302,557Direct (D) Yes
F4
  • F4 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
Open filing 0002021233-26-000012 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Hanson Kristopher Officer: General Counsel
S

Open market or private sale of non-derivative or derivative security

Voting Common Stock
Disposed (D)4,77636.45
174,085.2

Derived: shares × price per share. Exact value 174085.20.

150,295Direct (D) No
F1, F4
  • F1 Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary sale by the Reporting Person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001789970-26-000012 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 105

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
FCPM III SERVICES B.V. Partly reported under another manager4,428,328 SH45,124,662 dollarsHigher by 1,201,928 Prior quarter: 3,226,400Open filing 0001193125-26-462149 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager3,599,556 SH36,679,475 dollarsHigher by 1,651,244 Prior quarter: 1,948,312Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Nan Fung Group Holdings Ltd Partly reported under another manager2,300,328 SH23,440,342 dollarsHigher by 1,329,075 Prior quarter: 971,253Open filing 0001012975-26-001047 Filed 2026-11-13 Dispute this row
NOVO HOLDINGS A/S 2,086,622 SH21,262,678 dollarsLower by 1,600,000 Prior quarter: 3,686,622Open filing 0001388325-26-000051 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager1,712,729 SH17,452,709 dollarsHigher by 687,595 Prior quarter: 1,025,134Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager1,541,940 SH15,712,368 dollarsHigher by 718,384 Prior quarter: 823,556Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Deep Track Capital, LP 1,318,101 SH13,431,449 dollarsNot in the prior quarter’s filings read Open filing 0001856083-26-000006 Filed 2026-11-16 Dispute this row
BAKER BROS. ADVISORS LP 1,166,763 SH11,889,315 dollarsHigher by 802,058 Prior quarter: 364,705Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager1,132,288 SH11,539 dollarsLower by 290,647 Prior quarter: 1,422,935Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
T. Rowe Price Investment Management, Inc. 945,216 SH9,632 dollarsLower by 1,836,512 Prior quarter: 2,781,728Open filing 0001897612-26-000766 Filed 2026-11-16 Dispute this row
Sanofi 912,041 SH9,293,698 dollarsUnchanged Prior quarter: 912,041Open filing 0001193125-26-448717 Filed 2026-11-05 Dispute this row
5AM Venture Management, LLC 741,893 SH7,559,890 dollarsLower by 208,118 Prior quarter: 950,011Open filing 0001799883-26-000004 Filed 2026-11-16 Dispute this row
ADAR1 Capital Management, LLC 725,165 SH7,389,431 dollarsHigher by 698,668 Prior quarter: 26,497Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
Velan Capital Investment Management LP 624,703 SH6,365,724 dollarsHigher by 131,810 Prior quarter: 492,893Open filing 0001848809-26-000006 Filed 2026-11-16 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager612,310 SH6,239,438 dollarsHigher by 606,510 Prior quarter: 5,800Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
Pivotal bioVenture Partners Investment Advisor LLC Partly reported under another manager611,446 SH6,230,635 dollarsUnchanged Prior quarter: 611,446Open filing 0001012975-26-001045 Filed 2026-11-13 Dispute this row
Blue Owl Capital Holdings LP Partly reported under another manager556,371 SH5,669,420 dollarsLower by 173,558 Prior quarter: 729,929Open filing 0001193125-26-459653 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 516,022 SH5,258,264 dollarsHigher by 507,024 Prior quarter: 8,998Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager440,731 SH4,492,445 dollarsHigher by 38,680 Prior quarter: 402,051Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Point72 Asset Management, L.P. 426,261 SH4,343,600 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 423,678 SH4,317,279 dollarsHigher by 294,837 Prior quarter: 128,841Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Capital World Investors Partly reported under another manager415,760 SH4,236,594 dollarsHigher by 30 Prior quarter: 415,730Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 396,076 SH4,036,014 dollarsLower by 388,074 Prior quarter: 784,150Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Trexquant Investment LP Partly reported under another manager363,736 SH3,706,470 dollarsHigher by 299,944 Prior quarter: 63,792Open filing 0001633445-26-000008 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager313,586 SH3,195,441 dollarsLower by 538,564 Prior quarter: 852,150Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
LAZARD ASSET MANAGEMENT LLC 263,905 SH2,689,192 dollarsHigher by 183,823 Prior quarter: 80,082Open filing 0001207017-26-000051 Filed 2026-11-16 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager245,219 SH2,498,782 dollarsHigher by 174,735 Prior quarter: 70,484Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Partly reported under another manager170,862 SH1,741,084 dollarsUnchanged Prior quarter: 170,862Open filing 0001520354-26-000046 Filed 2026-11-13 Dispute this row
DAFNA Capital Management LLC 155,579 SH1,585,350 dollarsLower by 15,427 Prior quarter: 171,006Open filing 0001389933-26-000010 Filed 2026-11-16 Dispute this row
TD ASSET MANAGEMENT INC 140,888 SH1,430,013 dollarsHigher by 86,362 Prior quarter: 54,526Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager129,095 SH1,315,478 dollarsHigher by 12,443 Prior quarter: 116,652Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 122,473 SH1,248,000 dollarsLower by 14,345 Prior quarter: 136,818Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 120,871 SH1,231,675 dollarsHigher by 24,110 Prior quarter: 96,761Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
SUPERSTRING CAPITAL MANAGEMENT LP 118,304 SH1,205,518 dollarsLower by 7,128 Prior quarter: 125,432Open filing 0001931118-26-000011 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 116,464 SH1,186,768 dollarsLower by 6,671 Prior quarter: 123,135Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager102,232 SH1,041,744 dollarsLower by 19,796 Prior quarter: 122,028Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
BARCLAYS PLC Partly reported under another manager85,813 SH874,434 dollarsHigher by 72,838 Prior quarter: 12,975Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager85,475 SH870,990 dollarsHigher by 59,724 Prior quarter: 25,751Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
HRT FINANCIAL LP 83,737 SH853 dollarsHigher by 31,754 Prior quarter: 51,983Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
MANUFACTURERS LIFE INSURANCE COMPANY, THE Partly reported under another manager83,274 SH848,562 dollarsHigher by 76,234 Prior quarter: 7,040Open filing 0001145443-26-000111 Filed 2026-11-13 Dispute this row
Quadrature Capital Ltd Partly reported under another manager74,485 SH759,002 dollarsNot in the prior quarter’s filings read Open filing 0001651424-26-000014 Filed 2026-11-13 Dispute this row
XTX Topco Ltd Partly reported under another manager63,396 SH646,005 dollarsHigher by 38,477 Prior quarter: 24,919Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager60,716 SH618,697 dollarsHigher by 22,412 Prior quarter: 38,304Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
CITIGROUP INC Partly reported under another manager59,173 SH602,973 dollarsHigher by 42,122 Prior quarter: 17,051Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
Jump Financial, LLC Partly reported under another manager58,461 SH595,718 dollarsHigher by 33,239 Prior quarter: 25,222Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
Schonfeld Strategic Advisors LLC 54,016 SH550,422 dollarsNot in the prior quarter’s filings read Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager34,800 SH354,612 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
Nuveen, LLC Partly reported under another manager30,957 SH315,451 dollarsHigher by 13,036 Prior quarter: 17,921Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager30,218 SH307,922 dollarsLower by 192 Prior quarter: 30,410Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager29,369 SH299,270 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Paradigm Biocapital Advisors LP 685,852 SH
  • Siren, L.L.C. 450,000 SH
  • Freestone Grove Partners LP 168,912 SH
  • Sixth Street Partners Management Company, L.P. 136,818 SH
  • STEMPOINT CAPITAL LP 106,906 SH
  • SEVEN GRAND MANAGERS, LLC 100,000 SH
  • Boxer Capital Management, LLC 75,000 SH
  • Burkehill Global Management, LP 75,000 SH
  • WELLINGTON MANAGEMENT GROUP LLP 51,917 SH
  • Jain Global LLC 45,551 SH
  • BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,000 SH
  • Weiss Asset Management LP 33,094 SH
  • Rafferty Asset Management, LLC 13,853 SH
  • Quantinno Capital Management LP 11,339 SH
  • Jupiter Research Capital (Asia) Ltd 8,018 SH
  • AMERICAN CENTURY COMPANIES INC 7,470 SH
  • MetLife Investment Management, LLC 7,353 SH
  • PROFUND ADVISORS LLC 6,956 SH
  • RENAISSANCE TECHNOLOGIES LLC 6,937 SH
  • RAYMOND JAMES FINANCIAL INC 6,455 SH
  • Invesco Ltd. 5,729 SH
  • Aster Capital Management (DIFC) Ltd 1,480 SH
  • Pinnacle Wealth Planning Services, Inc. 1,265 SH
  • Penserra Capital Management LLC 1,088 SH
  • MERCER GLOBAL ADVISORS INC /ADV 590 SH
  • NISA INVESTMENT ADVISORS, LLC 400 SH
  • Pacer Advisors, Inc. 231 SH
  • Versant Capital Management, Inc 50 SH
  • SJS Investment Consulting Inc. 18 SH
  • Integrated Wealth Concepts LLC 7 SH
  • Larson Financial Group LLC 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
T. Rowe Price Investment Management, Inc. COMMON STOCK1.7945,21609/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 2Open filing 0001897612-26-000762 Dispute this row
Forbion Growth Opportunities Fund III Cooperatief U.A. Voting Common Stock, par value $0.0001 per share8.44,428,32809/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-462143 Dispute this row
Forbion Growth III Management B.V. Voting Common Stock, par value $0.0001 per share8.44,428,32809/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-462143 Dispute this row
Catalyst4, Inc. Common Stock, $0.0001 par value per share49.927,536,011.0008/14/2026 Filed 2026-08-18SCHEDULE 13D/AAmendment 2Open filing 0001104659-26-098444 Dispute this row
Robert Brown Common Stock, $0.0001 par value per share49.927,536,011.0008/14/2026 Filed 2026-08-18SCHEDULE 13D/AAmendment 2Open filing 0001104659-26-098444 Dispute this row
Ekemini Riley Common Stock, $0.0001 par value per share49.927,536,011.0008/14/2026 Filed 2026-08-18SCHEDULE 13D/AAmendment 2Open filing 0001104659-26-098444 Dispute this row
Mark Vorsatz Common Stock, $0.0001 par value per share49.927,536,011.0008/14/2026 Filed 2026-08-18SCHEDULE 13D/AAmendment 2Open filing 0001104659-26-098444 Dispute this row
Nan Fung Group Holdings Limited Common Stock, par value $0.0001 per share5.52,915,87408/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
NF Investment Holdings Limited Common Stock, par value $0.0001 per share5.52,911,77408/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
Nan Fung Life Sciences Holdings Limited Common Stock, par value $0.0001 per share2.41,283,05208/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
NFLS Platform Holdings Limited Common Stock, par value $0.0001 per share1.3671,60608/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
Pivotal Life Sciences Holdings Limited Common Stock, par value $0.0001 per share1.2611,44608/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
Pivotal Partners Ltd Common Stock, par value $0.0001 per share1.2611,44608/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
Pivotal bioVenture Partners Fund II G.P. Ltd Common Stock, par value $0.0001 per share1.2611,44608/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
Pivotal bioVenture Partners Fund II, L.P. Common Stock, par value $0.0001 per share1.2611,44608/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
NFLS Beta Limited Common Stock, par value $0.0001 per share1.3671,60608/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
Permwell Management Limited Common Stock, par value $0.0001 per share3.11,628,72208/13/2026 Filed 2026-08-20SCHEDULE 13GOpen filing 0001012975-26-000807 Dispute this row
Catalyst4, Inc. Common Stock, $0.0001 par value per share47.920,906,689.0007/30/2026 Filed 2026-08-03SCHEDULE 13D/AAmendment 1Open filing 0001104659-26-089960 Dispute this row
Robert Brown Common Stock, $0.0001 par value per share47.920,906,689.0007/30/2026 Filed 2026-08-03SCHEDULE 13D/AAmendment 1Open filing 0001104659-26-089960 Dispute this row
Ekemini Riley Common Stock, $0.0001 par value per share47.920,906,689.0007/30/2026 Filed 2026-08-03SCHEDULE 13D/AAmendment 1Open filing 0001104659-26-089960 Dispute this row
Mark Vorsatz Common Stock, $0.0001 par value per share47.920,906,689.0007/30/2026 Filed 2026-08-03SCHEDULE 13D/AAmendment 1Open filing 0001104659-26-089960 Dispute this row
Novo Holdings A/S Voting Common Stock, par value $0.0001 per share4.92,086,622.0007/30/2026 Filed 2026-07-31SCHEDULE 13D/AAmendment 1Open filing 0001388325-26-000034 Dispute this row
T. Rowe Price Investment Management, Inc. COMMON STOCK7.43,137,55803/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0001897612-26-000505 Dispute this row
Forbion Growth Opportunities Fund III Cooperatief U.A. Voting Common Stock, par value $0.0001 per share7.13,226,40012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001193125-26-053187 Dispute this row
Forbion Growth III Management B.V. Voting Common Stock, par value $0.0001 per share7.13,226,40012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001193125-26-053187 Dispute this row
T. Rowe Price Investment Management, Inc. COMMON STOCK6.22,799,18012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001897612-26-000296 Dispute this row
Catalyst4, Inc. Common Stock, $0.0001 par value per share45.119,697,464.0010/28/2025 Filed 2025-11-20SCHEDULE 13DOpen filing 0001104659-25-114697 Dispute this row
Robert Brown Common Stock, $0.0001 par value per share45.119,697,464.0010/28/2025 Filed 2025-11-20SCHEDULE 13DOpen filing 0001104659-25-114697 Dispute this row
Ekemini Riley Common Stock, $0.0001 par value per share45.119,697,464.0010/28/2025 Filed 2025-11-20SCHEDULE 13DOpen filing 0001104659-25-114697 Dispute this row
Mark Vorsatz Common Stock, $0.0001 par value per share45.119,697,464.0010/28/2025 Filed 2025-11-20SCHEDULE 13DOpen filing 0001104659-25-114697 Dispute this row
Novo Holdings A/S Voting Common Stock, par value $0.0001 per share8.43,686,622.0010/28/2025 Filed 2025-11-04SCHEDULE 13DOpen filing 0001388325-25-000021 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,694,798 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015111,180
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to MapLight Therapeutics, Inc.